Sonoma Pharmaceuticals Inc (SNOA) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Sonoma Pharmaceuticals Inc   (NASDAQ: SNOA)
 

Sonoma Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Sonoma Pharmaceuticals Inc inventory turnover ratio, the Sonoma Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 3.9 in the second quarter 2026, SNOA's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Sonoma Pharmaceuticals Inc in Sep 30 2026 quarter, has decreased to 94 days, compare to 101 days, in the Jun 30 2026 quarter.

Within Healthcare sector 116 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 269 in the first quarter 2026, to 1335.

SNOA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sonoma Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SNOA Inventory Turnover Ratio (Sep 30 2026)
II. Quarter		 (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter
Y / Y Inventory Growth -3.47 % -0.42 % 25.25 % 17.82 % 28.09 %
Y / Y Cost of Sales Growth 25.34 % 50.1 % 51.84 % 17.65 % 57.08 %
Inventory Turnover Ratio (TTM) 3.9 3.63 3.28 3.12 3.13
SNOA's Total Ranking # 1335 # 269 # 550 # #
Average inventory processing period 94 101 111 117 117
Seq. Inventory Growth -7.34 % 3.7 % -1.4 % 1.9 % -4.42 %
Seq. Cost of Sales Growth 14.05 % 13.28 % 25.23 % -22.53 % 36.57 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 46
Healthcare Sector # 117
Overall Market # 1335

Inventory Turnover Ratio Statistics
High Average Low
5.83 2.55 -0.11
(Dec 31 2018)   (Sep 30 2012)



SNOA Company Profile >> Back to SNOA Efficiency Comparisons >> Compare SNOA Inventory Turnover Ratio to its Competitors

Financial Statements
Sonoma Pharmaceuticals Inc 's Inventories $ 4 Millions Visit SNOA's Balance sheet
Sonoma Pharmaceuticals Inc 's Cost of Revenues TTM $ 14 Millions Visit SNOA's Income Statement
What are SNOA's Sales? Visit SNOA's Sales by Segment

Other Inventory Turnover Ratios
Sonoma Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SNOA's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SNOA's Competitors
Inventory Turnover Ratio for SNOA's Suppliers
Inventory Turnover Ratio for SNOA's Customers

You may also want to know
SNOA's Sales Growth Rates SNOA's Pe Price to earnings ratio SNOA's Receivables Turnover Ratio SNOA's Stock Quote
SNOA's Net Income Growth Rates SNOA's Ps Price to Sales ratio SNOA's Sales per Employee SNOA's Asset Turnover Ratio
SNOA's Net Margin SNOA's Pb Price to Book ratio SNOA's Financial Strength Ratios SNOA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Tarsus Pharmaceuticals Inc   10.68 $ 49.325  Millions$ 5  Millions
Sotera Health Company  10.25 $ 558.509  Millions$ 54  Millions
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions

Date modified: 2026-11-11T14:00:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.